Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 10
2005 14
2006 21
2007 19
2008 11
2009 17
2010 26
2011 21
2012 24
2013 25
2014 21
2015 25
2016 19
2017 26
2018 24
2019 18
2020 35
2021 30
2022 26
2023 9
2024 16
2025 20
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review.
Felicetti F, Mazzilli R, Gori S, Gallo M, Cortellini A, D'Oronzo S, Gristina V, Argentiero A, Candido R, Del Re M, Fogli S, Franchina T, Giuffrida D, Marino G, Monami M, Montagnani M, Morviducci L, Natalicchio A, Ragni A, Renzelli V, Sciacca L, Tuveri E, Giorgino F, Verzé M, Zatelli MC, Arvat E, Perrone F, Stracci F, Aimaretti G, Avogaro A, Buzzetti R, Silvestris N, Faggiano A. Felicetti F, et al. Among authors: avogaro a. J Endocrinol Invest. 2025 Dec 3. doi: 10.1007/s40618-025-02764-5. Online ahead of print. J Endocrinol Invest. 2025. PMID: 41335192
Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.
Fadini GP, Giaccari A, Broglio F, Nollino L, Fattor B, Anichini R, Meregalli G, Avogaro A, Consoli A; GLIMPLES Study Investigators. Fadini GP, et al. Among authors: avogaro a. Lancet Reg Health Eur. 2025 Oct 15;59:101499. doi: 10.1016/j.lanepe.2025.101499. eCollection 2025 Dec. Lancet Reg Health Eur. 2025. PMID: 41142657 Free PMC article.
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.
Fadini GP, Longato E, Poletto S, Giaccari A, Ghiani M, Strazzabosco M, Trombetta M, Penno G, Avogaro A, Solini A, Consoli A; GLIMPLES study investigators and DARWIN‐Renal study investigators. Fadini GP, et al. Among authors: avogaro a. Diabetes Obes Metab. 2025 Dec;27(12):7431-7440. doi: 10.1111/dom.70151. Epub 2025 Sep 24. Diabetes Obes Metab. 2025. PMID: 40990044 Free PMC article.
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.
Fadini GP, Longato E, Morieri ML, Broglio F, Aimaretti G, Russo GT, Anichini R, Ghiani M, Avogaro A, Solini A; DARWIN‐Renal Study Investigators. Fadini GP, et al. Among authors: avogaro a. Diabetes Obes Metab. 2025 Sep;27(9):5182-5191. doi: 10.1111/dom.16569. Epub 2025 Jul 2. Diabetes Obes Metab. 2025. PMID: 40600449 Free PMC article.
421 results